👆👆👆👆👆Suggestion :- SELL IF PRICE COMES AGAIN AT 745 WITH SL OF 747 FOR TARGET OF 735
EXPECTATION OF TARGET- 1 DAYS
SIGNAL TYPE - STRONG TIME FRAME- 1 HOURS
FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors
forum
LUPIN Share Price Discussion
Lupin Ltd.
Sector: Pharmaceuticals and health care
Sector: Pharmaceuticals and health care
LUPIN Long Term Analysts Rating
- ★★
- ★★
- ★★
- ★★
- ★★
3.2/5 (18 Ratings)
LUPIN Share Price *
739.65 +1.8 (0.24%)
* (quote may be delayed)
Find answers to all your questions on live LUPIN message board: Is LUPIN buy or sell? Should I buy LUPIN shares? Why are LUPIN shares falling? Should I invest in LUPIN stock?
You can also check LUPIN share price target recommended by brokerages.
LUPIN Discussion Forum
@rkk-S1XHdc69E • Reputation: 80
RKK in LUPINBut Lupin future @ 735-740 SL below 725 target ...
Even market fall but Lupin was intact, closed c2c or small profits
Like
reply
Reply
@tradingfab • Reputation: 752
22-01-20
LUPIN JAN PE 730 (Intraday)
only Above @ 9.30
Like
reply
Reply (1)
Latest replies
cancel the order as buy price above @9.30 not yet triggered
@mpriceplotting • Reputation: 1,035
TTTE bullish for Lupin is 733
and Many more trade setup which you can do on your own with levels and just 1 hr in evening.
Like
reply
Reply
@rkk-S1XHdc69E • Reputation: 80
But Lupin future @ 735-740 SL below 725 target 750-754-758-762
Like
reply
Reply
@TTA • Reputation: 8,717
LUPIN JAN20 FUT
Like
reply
Reply (2)
Latest replies
Intraday?
@prudhvii time frame written in call
@konartradetalk • Reputation: -595
💠💠
YOUR FREE EQUITY CASH CALL FOR THIS FORUM TODAY:
SELL LUPIN AT THE VERY BEGINING
STRICT STOP LOSS - 775
1ST TARGET - 759
2ND TARGET - 755
3RD TARGET - 750
## GO WITH SAFER QUANTITY ##
Disclaimer: All my Views/Suggestions/Calls are for Education Purpose Only. Please consult w...
Read more...
Like
reply
Reply
@stocktrendr • Reputation: 175
Lupin received five observations from the US health regulator after inspection of its Vizag facility in Andhra Pradesh. The inspection of company's Vizag API manufacturing facility by the United States Food and Drug Administration (USFDA) has been completed, Lupin said in a filin...
Read more...
Like
reply
Reply
@invictotrader • Reputation: 2,085
Lupin gets 5 observations from USFDA for its Vizag facility The inspection was carried out between January 13, 2020 and January 17, 2020, it added.
Like
reply
Reply
@sridharbalakrishnan • Reputation: 9,963
Lupin’s Troubles In U.S. Run Deep
Five plants of Lupin Ltd. have come under the U.S. drug regulator’s scanner over the last one year as the nation’s sixth-largest drugmaker failed to resolve quality issues amid intense competition and pricing pressure in its largest market.
...
Read more...
Like
reply
Reply
@commodityBiz • Reputation: 2,552
👆👆👆👆👆👆👆👆Suggestion :- SELL IF PRICE COMES AGAIN AT 765 WITH SL OF 768 FOR TARGET OF 754
EXPECTATION OF TARGET- 1 DAYS
SIGNAL TYPE - STRONG TIME FRAME- 1 HOURS
Like
reply
Reply (1)
Latest replies
Ye saala Madarchod ka bacha hai . Iski maa randi hai . Budhiya ko koi nhi chodta to isne yha logon se paisa chori karne ka business khara kar rakha hai . Ye haramkhoro ko kuch nhi aata . Sala iska baap goo saaf karta tha aur iski biwi abhi bhi randi khana join ki hai . bhai log ...
@ravikanthchopperla • Reputation: 10,618
Lupin share price falls 2% after USFDA classifies Tarapur unit as OAI
USFDA inspected company's manufacturing (API) facility between September 16 to September 20.
USFDA inspected company's manufacturing (API) facility between September 16 to September 20.
Moneycontrol
1
reply
Reply
@calls • Reputation: 1,206
*UPDATE*
LUPIN GIVEN AT 770
NOW MADE 742 + 28 * 700 = 19600 PER LOT RUNNING
CHHAPO INDIA CHHAPO
1
reply
Reply
@Vaibhavbarge • Reputation: 24,250
Lupin: The pharma company on Saturday said it has received two observations from the US health regulator following the inspection of its Nagpur manufacturing facility. A prior approval inspection was carried out by the United States Food and Drug Administration at the company's N...
Read more...
Like
reply
Reply
@invictotrader • Reputation: 2,085
Lupin gets 2 observations from USFDA for Nagpur facility "The inspection closed with two 483 observations," Lupin said.
Like
reply
Reply
@Sharemarket • Reputation: -1,368
For Short Term Buy Lupin @ 795 Target 810/840+++ Stop loss 786
Like
reply
Reply
@commodityBiz • Reputation: 2,552
👆👆👆👆👆👆👆👆Suggestion :- SELL IF PRICE COMES AGAIN AT 764 WITH SL OF 767 FOR TARGET OF 754
EXPECTATION OF TARGET- 1 DAYS
SIGNAL TYPE - STRONG TIME FRAME- 1 HOURS
Like
reply
Reply
@tradingfab • Reputation: 752
08-01-20 Intraday SELL LUPIN in cash
only Below @ 753
Like
reply
Reply (3)
Latest replies
LTP 752.30 🔥🔥🔥
LTP 951.15 🔥🔥💥
low 750.25 🔥🔥💥💥
@tradingfab • Reputation: 752
08-01-20 Intraday SELL LUPIN in cash
only Below @ 751.50
Like
reply
Reply (1)
Latest replies
cancel the order as sell price below @751.50 not yet triggered
@ravikanthchopperla • Reputation: 10,618
Lupin: LCP 757.55 having next supports at 737 and 720 and resistance being at 778 and 815.
Like
reply
Reply
@commodityBiz • Reputation: 2,552
👆👆👆👆👆👆👆👆Suggestion :- SELL IF PRICE COMES AGAIN AT 765 WITH SL OF 768 FOR TARGET OF 760
EXPECTATION OF TARGET- 1 DAYS
SIGNAL TYPE - STRONG TIME FRAME- 1 HOURS
Like
reply
Reply
@databot • Reputation: 1,382
Motilal Oswal target on LUPIN
Date: 12-Nov-19
Broker: Motilal Oswal
Price @ Call: 731.45
Target: 860
Recommendation: BUY
Like
reply
Reply
@databot • Reputation: 1,382
Motilal Oswal target on LUPIN
Date: 12-Nov-19
Broker: Motilal Oswal
Price @ Call: 731.45
Target: 860
Recommendation: BUY
Like
reply
Reply
@sridharbalakrishnan • Reputation: 9,963
Performance
Entry 759.00 to 772.95
*profit 9800*
Like
reply
Reply (2)
Latest replies
Can I have your contact number please
Good morning, u can connect on 9845031889
@invictotrader • Reputation: 2,085
Lupin's Ankleshwar Facility Wins Frost & Sullivan's India Manufacturing Excellence Awards 2019
Like
reply
Reply
@commodityBiz • Reputation: 2,552
👆👆👆👆👆👆👆👆Suggestion :- SELL IF PRICE COMES AGAIN AT 759 WITH SL OF 767 FOR TARGET OF 475
EXPECTATION OF TARGET- 1-2 DAYS
SIGNAL TYPE - STRONG TIME FRAME- 1 HOURS
Like
reply
Reply
@rachanaGoldforest • Reputation: 403
Goldforest in LUPINSell lupin 769 Target 765-61 Sl 774
All done 💰💰💰💰💰💸💸💸
Like
reply
Reply
@rachanaGoldforest • Reputation: 403
Goldforest in LUPINSell lupin 769 Target 765-61 Sl 774
T1done 💰💰💰💰
1
reply
Reply
@rachanaGoldforest • Reputation: 403
Goldforest in LUPINSell lupin 769 Target 765-61 Sl 774
766.05🔥🔥🔥🔥
1
reply
Reply
@rachanaGoldforest • Reputation: 403
Goldforest in LUPINSell lupin 769 Target 765-61 Sl 774
767.25🔥🔥🔥🔥
1
reply
Reply
@TTA • Reputation: 8,717
Lupin has got USFDA approval for the generic version of Merck's Diprolene (Betamethasone Dipropionate) ointment, 0.05% in US. The drug, a corticosteroid indicated for relief from certain skin conditions, had annual sales of ~US$22 million in the US (IQVIA MAT September 2019). The...
Read more...
Like
reply
Reply
@sridharbalakrishnan • Reputation: 9,963
Futures & Options educational trades for the week 23.12.19 to 27.12.19*
(My trade rules given below apply)
Lupin* cmp 772.10 buy upto 755.00 stop 743.00 target 814.00+
1
reply
Reply
@commodityBiz • Reputation: 2,552
👆👆👆👆👆👆👆👆Suggestion :- BUY IF PRICE COMES AGAIN BETWEEN 771-771.50 WITH SL OF 768 FOR TARGET OF 778
EXPECTATION OF TARGET- 1 DAYS
SIGNAL TYPE - STRONG TIME FRAME- 1 HOURS
Like
reply
Reply
@invictotrader • Reputation: 2,085
Lupin receives approval for Betamethasone Dipropionate Ointment USP (Augmented)
Like
reply
Reply
@invictotrader • Reputation: 2,085
Lupin gets USFDA nod to market skin ointment The approval by the United States Food and Drug Administration (USFDA) is to market its generic Betamethasone Dipropionate ointment USP (augmented), 0.05 per cent, it added.
Like
reply
Reply
@invictotrader • Reputation: 2,085
Lupin's Alliance Partner Concord Receives Approval for Mycophenolic Acid Delayed Release Tablets USP
Like
reply
Reply
@invictotrader • Reputation: 2,085
Lupin share price gains on USFDA nod for Mycophenolic drug With this approval, the company said it would market a generic equivalent of Myfortic delayed release tablets of Novartis Pharmaceuticals Corporation,
Like
reply
Reply
- NewsBotOct 23 4:13 PM
Rakesh Jhunjhunwala raises stake in 5 stocks which fell up to 40% in 2019MoneycontrolNewsBotOct 23 3:43 PM
Q2 portfolio rejig: Rakesh Jhunjhunwala raises stake in 5 stocks which fell up to 40% in 2019MoneycontrolNewsBotOct 23 2:23 PM
Market Headtstart: Nifty50 seen opening flat; Axis Bank, RBL Bank in focusMoneycontrolNewsBotOct 18 9:28 PM
Lupin gains 2% as Nagpur unit receives EIR from USFDAMoneycontrolNewsBotOct 14 9:18 PM
Lupin Q2 PAT may dip 22% YoY to Rs. 206.5 cr: EmkayMoneycontrolNewsBotOct 14 1:53 PM
Stocks in the news: Infosys, Avenue Supermart, BoB, NMDC, Cadila Health, HULMoneycontrolNewsBotOct 14 1:23 PM
Market Headstart: Nifty seen opening flat; Bharti Airtel, HUL top buysMoneycontrolNewsBotOct 14 1:03 PM
A morning walk down Dalal Street | Nifty may test 11,400 if it stays above 11,189; HUL in focusMoneycontrolNewsBotOct 12 2:33 AM
Lupin plans to file Etanercept, Pegfilgrastim biosimilars in US by Q4FY20MoneycontrolNewsBotOct 10 4:48 PM
Morgan Stanley bullish on these 2 pharma stocks which could give 32-47% returnMoneycontrol
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.